Pharma-Bio Serv (OTCMKTS:PBSV) Share Price Passes Below Two Hundred Day Moving Average – What’s Next?

Pharma-Bio Serv, Inc. (OTCMKTS:PBSV)’s share price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.56 and traded as low as $0.42. Pharma-Bio Serv shares last traded at $0.43, with a volume of 8,200 shares trading hands.

Pharma-Bio Serv Trading Up 2.4 %

The company has a fifty day moving average of $0.54 and a 200-day moving average of $0.56. The company has a market capitalization of $9.86 million, a price-to-earnings ratio of -14.33 and a beta of 0.53.

Pharma-Bio Serv (OTCMKTS:PBSV) last released its quarterly earnings results on Monday, March 17th. The company reported $0.37 EPS for the quarter, beating the consensus estimate of $0.02 by $0.35. Pharma-Bio Serv had a negative net margin of 8.18% and a negative return on equity of 5.61%. The firm had revenue of $2.47 million for the quarter, compared to analyst estimates of $2.70 million. As a group, equities research analysts expect that Pharma-Bio Serv, Inc. will post 0.11 EPS for the current year.

Pharma-Bio Serv Dividend Announcement

The business also recently announced a dividend, which was paid on Thursday, March 20th. Shareholders of record on Friday, February 28th were given a $0.075 dividend. The ex-dividend date of this dividend was Friday, February 28th. Pharma-Bio Serv’s payout ratio is currently -375.00%.

Pharma-Bio Serv Company Profile

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.